{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:39:17Z","timestamp":1773923957290,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma","doi-asserted-by":"publisher","award":["Unknown"],"award-info":[{"award-number":["Unknown"]}],"id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/14656566.2016.1269749","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T21:31:43Z","timestamp":1482096703000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile"],"prefix":"10.1080","volume":"18","author":[{"given":"Carle","family":"Paul","sequence":"first","affiliation":[{"name":",","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Bang","sequence":"additional","affiliation":[{"name":",","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041320"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.04.014"},{"issue":"3","key":"e_1_3_2_6_1","first-page":"280","article-title":"The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey","volume":"137","author":"Krueger G","year":"2001","unstructured":"Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280\u2013284.","journal-title":"Arch Dermatol"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S81428"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1193"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S24087"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.12.032"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e6712"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0948"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.130"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.492778"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04525.x"},{"key":"e_1_3_2_16_1","unstructured":"LEO Pharma. Enstilar (calcipotriene and betamethasone dipropionate) foam: US prescribing information. 2016. Available from: http:\/\/www.fda.gov (accessed Oct 2016)."},{"key":"e_1_3_2_17_1","unstructured":"LEO Pharma. Enstilar (calcipotriol\/betamethasone dipropionate) cutaneous foam: UK summary of product characteristics. 2016. Available from: https:\/\/www.medicines.org.uk\/emc (accessed Oct 2016)."},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475415597094"},{"key":"e_1_3_2_19_1","first-page":"S33","article-title":"Enhanced in vitro skin penetration and antipsoriatic effect of fixed combination calcipotriol plus betamethasone dipropionate in an innovative foam vehicle","volume":"134","author":"Hollesen Basse L","year":"2014","unstructured":"Hollesen Basse L, Olesen M, Lacour JP, et al. Enhanced in vitro skin penetration and antipsoriatic effect of fixed combination calcipotriol plus betamethasone dipropionate in an innovative foam vehicle. J Invest Dermatol. 2014;134:S33. abst 192","journal-title":"J Invest Dermatol"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13714"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-016-0125-6"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0269-7"},{"issue":"2","key":"e_1_3_2_23_1","first-page":"34","article-title":"Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, Phase II study","volume":"9","author":"Lebwohl M","year":"2016","unstructured":"Lebwohl M, Tyring S, Bukhalo M, et al. Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, Phase II study. J Clin Aesthet Dermatol. 2016;9(2):34\u201341.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1083935"},{"issue":"12","key":"e_1_3_2_25_1","first-page":"1468","article-title":"Efficacy and safety of calcipotriene plus betamethasone dipropionate aerosol foam in patients with psoriasis vulgaris - a randomized Phase III study (PSO-FAST)","volume":"14","author":"Leonardi C","year":"2015","unstructured":"Leonardi C, Bagel J, Yamauchi P, et al. Efficacy and safety of calcipotriene plus betamethasone dipropionate aerosol foam in patients with psoriasis vulgaris - a randomized Phase III study (PSO-FAST). J Drugs Dermatol. 2015;14(12):1468\u20131477.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-62"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13859"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_3_2_29_1","article-title":"The aerosol foam formulation of the fixed combination calcipotriene plus betamethasone dipropionate improves the health-related quality of life in patients with psoriasis vulgaris: results from the randomized PSO-FAST study","author":"Leonardi C","year":"2016","unstructured":"Leonardi C, Bagel J, Yamauchi P, et al. The aerosol foam formulation of the fixed combination calcipotriene plus betamethasone dipropionate improves the health-related quality of life in patients with psoriasis vulgaris: results from the randomized PSO-FAST study. J Drugs Dermatol. 2016;15(8):981\u2013987.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_2_30_1","article-title":"More rapid improvement in quality of life with fixed combination calcipotriene plus betamethasone dipropionate aerosol foam versus topical suspension (PSO-ABLE study in patients with psoriasis vulgaris)","author":"Paul C","year":"2016","unstructured":"Paul C, Stein Gold L, Cambazard F, et al. More rapid improvement in quality of life with fixed combination calcipotriene plus betamethasone dipropionate aerosol foam versus topical suspension (PSO-ABLE study in patients with psoriasis vulgaris). J Am Acad Dermatol. 2016;74(5):AB260 (abst p3712).","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_2_31_1","article-title":"Fixed combination calcipotriene plus betamethasone dipropionate aerosol foam is well tolerated in patients with psoriasis vulgaris (pooled data from three randomized controlled studies)","author":"Menter A","year":"2016","unstructured":"Menter A, Stein GL, Koo J, et al. Fixed combination calcipotriene plus betamethasone dipropionate aerosol foam is well tolerated in patients with psoriasis vulgaris (pooled data from three randomized controlled studies). Skinmed. 2016. [Epub ahead of print]","journal-title":"Skinmed"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.855"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12445"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04060.x"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2016.1269749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:27:36Z","timestamp":1770917256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2016.1269749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/14656566.2016.1269749"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2016.1269749","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-09-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}